Sep 16

Treatment innovations in hypertrophic and keloids scars!

Published in an article on https://www.woundsinternational.com/ they talk about the treatment innovations in keloids scars and hypertrophic.
“This article examines the latest innovations and research in the diagnosis and treatment of hypertrophic and keloids scars. It looks at the latest evidence for targeting molecular and cellular pathways as well as emphasising that speed of treatment is crucial in preventing scarring. The authors also outline the direction of future research into scarring and make some recommendations for practice.”
We are just posting an introduction here to develop your interest and if you further want to read up on the entire article you can directly log on to their website and read it there. At the bottom of this reading we have pasted a link to their website where this article is posted.
INTRODUCTION (As posted on the website)

keloids

Hypertrophic and keloid scars are defined as benign hyperproliferative growths that occur as an abnormal response to wound healing [1]. As current aesthetic surgical techniques become more standardised and the results more predictable, there is a fine line between acceptable and unacceptable outcomes [2]. Consequently, current management of hypertrophic and keloid scars include a wide range of techniques, from traditional invasive methods to intra-lesional and topical application of agents designed to take effect on a cellular level [3].
To read the whole article kindly go onto the following link:
https://www.woundsinternational.com/practice-development/treatment-innovations-in-hypertrophic-and-keloid-scars

Aug 30

Are you wondering what Research Is Being Conducted on Pemphigus?

A lot of you must be wondering about this that is there any research being done on Pemphigus? Here we found useful article on National Institute of Arthritis and Musculoskeletal and Skin Diseases website.

Source: https://www.niams.nih.gov

We picked up this excerpt from the whole article which attracted our attention.

Here it is. Read on!

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), supports a broad range of research on pemphigus to better understand what causes various forms of the disease and to develop better treatments. When researchers began to understand that pemphigus is an autoimmune disease, they were able to target their laboratory studies on immune function and to apply research advances in other autoimmune diseases to pemphigus. They have already clarified that effective therapies against this disease must stop production of the antibodies that attack the skin cells.

Environmental and genetic risk factors. Researchers are trying to determine the environmental and genetic risk factors for pemphigus by studying populations that have high rates of the disease, such as people living in certain rural areas of Brazil.

Basic research. Scientists are conducting laboratory studies of antibodies that attack skin cells to determine how different antibodies contribute to this disease. They are also studying the genes involved when the body’s antibodies attack healthy tissue.

Pemphigus

Other NIAMS-supported researchers are studying animal models of various forms of pemphigus to define the events that trigger the development of the blistering skin and mucous membranes.

  •  Investigators have found that a certain protein, called p38 mitogen-activated protein kinase (p38 MAPK), is activated in mice with pemphigus, and that blocking this protein prevents blisters. This may lead to a way to prevent a specific immune response without having to suppress the entire immune system.
  • Desmoglein is the target of antibodies in pemphigus. Researchers are looking at how desmoglein functions as a cell adhesive and how pemphigus disrupts that function. Desmoglein also appears to have a role beyond that of cellular adhesion, and researchers are studying its role in forming skin cells.

Designing better treatment options. Other scientists are devising treatments to avoid the use of corticosteroids altogether. They are working to design drugs that more effectively inhibit antibody formation without the side effects that can occur with current treatments.

Hope you found this meaningful. For more information you can visit their website directly by clicking on the following link:

https://www.niams.nih.gov/Health_info/Pemphigus/default.asp#11

Aug 27

What can be expected after the treatment of Epididymitis?

Hello everyone! Hope you are having a good day. We have some interesting article for you on what to expect after the Treatment of Epididymitis? While researching online on the disease we came across this interesting and informational excerpt on the ugologyhealth.org.
Posting here the extract of a long article on the disease, causes, symptoms and other related headers for your information!
Reference: www.urologyhealth.org

What can be expected after treatment?

According to the source “Acute epididymitis and acute epididymo-orchitis: In the typical infectious case, it will take two to three days for you to notice improvement. If the redness does not subside and you do not start to feel better by that time, contact your physician. Complete resolution of symptoms will take longer. Discomfort can persist until the entire course of antibiotics is completed, and the firmness and swelling can takes months to resolve. Following the instructions to stay at bed rest with scrotal elevation for the first one to two days will help speed recovery. You should follow-up with your physician after treatment. In cases of tuberculous epididymitis that do not require orchiectomy, it takes months to resolve on medications, and there will likely be some shrinking of the testicle. Amidarone epididymitis improves after reducing the dose or stopping the drug, without any residual problems. Chemical epididymitis also resolves completely.

Epididymitis

Chronic epididymitis: Treatment is ongoing, and not curative. You may need to take medications for years, or until the symptoms resolve spontaneously. If epididymectomy is performed, relief of symptoms occurs in three out of four patients after a few weeks for surgical recovery. If surgery has not resolved your symptoms, then your doctor will try medical therapy again.
Acute orchitis: Following the acute phase of mumps orchitis, the pain resolves but there is often atrophy of the testicle.”

Resource Link:: https://www.urologyhealth.org/urology/index.cfm?article=114

Aug 26

You know who gets Tinea Versicolor?

American Academy of Dermatology published an article on who is affected by this disorder and the causes of it. While doing some online research on TV and some other disorder we found this very useful information which we found worth sharing so that a lot of you can know who is likely to get affected by this disorder and what really causes it.

Source: American Academy of Dermatology

Let’s find out according to AAD Who gets Tinea Versicolor !

They say “The yeast that Causes Tinea Versicolor lives on everyone’s skin. It is not clear why the yeast overgrows on some people’s skin and not others. We do know the following about Tinea Versicolor:

  •  People of all skin colors get it.
  • Teens and young adults are most susceptible because they have oily skin.
  • Older adults and children rarely get it unless they live in a tropical or subtropical area.
  • People who live in non-tropical areas often see tinea versicolor disappear during the cool, dry months.

Tinea Versicolor

Now let’s find out according to AAD what causes Tinea Versicolor !

Yeast normally live on our skin. When the yeast overgrows, it causes the skin disease tinea versicolor. It is believed that the following can cause the yeast to overgrow:

  •  Hot, humid weather.
  • Lots of sweating.
  • Oily skin.
  • A weakened immune system.

For more detailed information you can visit the website of American Academy of Dermatology where you can find first-hand information on the disorder. We will come up with more fresh research as soon as we come across something helpful and what we feel will make a difference in your life. Don’t ever hesitate to go to a dermatologist if you ever experience any symptoms that relate to this disorder. For details on symptoms you can click the disease by going to the search disease by name page the tab of which has been placed on our main website homepage.

By : Herbs Solutions By Nature

Aug 26

New ways to handle Bronchiectasis!

Here we’ve found a latest research on the treatment for Bronchiectasis while reading up on various articles regarding this disorder.
Source: Medicalnews.com
Written by: Grace Rattue
Found this article very interesting and worth sharing with you all. Pasting it here for reference!
The website state that “According to a study published in The Lancet, scientists have discovered an innovative treatment for non-cystic fibrosis bronchiectasis, a long-term lung disorder which results in breathlessness and persistent coughing.
At present, the global prevalence of the disorder, which occurs when airways in the lungs become abnormally widened, remains unknown, but enhanced screening methods indicate that diagnosis of the disease will most likely rise in the future. In the UK, an estimated 1 in every 1,000 adults suffers from non-cystic fibrosis bronchiectasis.
In order to determine if regular doses of azithromycin, an antibiotic with anti-inflammatory effects, had an impact on the frequency of exacerbations in patients with the disease, the team enrolled 141 bronchiectasis patients in New Zealand.
After six months the team discovered that 42 exacerbations occurred in the group receiving azithromycin vs. 103 exacerbations in the placebo group.

Bronchiectasis

Furthermore, patients taking the drug were less likely to develop an exacerbation than those in the placebo group. In the azithromycin group 31% of patients reported at least one exacerbation in the first six months of treatment vs. 66% of patients in the placebo group.
Dr Conroy Wong, of Auckland’s Middlemore Hospital in New Zealand, explained:
“Very few evidence-based treatments are available for the prevention and management of bronchiectasis exacerbations, and more are urgently needed. Our results show that azithromycin treatment for six months decreases the frequency of exacerbations and increases the time to first exacerbation. These benefits seem to persist for six months after the treatment is completed, suggesting that azithromycin could offer a new treatment option for some patients with bronchiectasis.”
In an associated comment, Dr. Robert Wilson and Professor Athol Wells of the Royal Brompton Hospital, London, explained: “The difficulties of undertaking this study in a specialty that has not attracted major public health investment or proactive involvement by public health groups should not be underestimated.”

Aug 22

Let’s discuss a bit about Retinal Vein Occlusion here

People who don’t have hypertension, high cholesterol, diabetes, don’t smoke or have not had a head injury can also suffer from Retinal Vein Occlusion. There is nothing much to worry about especially if your doctor says so. Trust him on this. The tests that are required usually are:

  •  Blood tests.
  • Blood test for Lupus.
  • Thrombophilia.
  • Fluorescein angiography.

Retinal Vein Occlusion

Some people worry too much about this disorder but normally it is a usual eyesight issue but when they see it on the diagnosis paper written Retinal Vein Occlusion they do get horrified that oh no! What is going to happen next? RELAX. Nothing! You will be alright! Just be patient and keep pace with the treatment and you’ll be fine. Also, don’t be careless when it comes to eyes like what your doctor has prescribed do follow the instructions carefully on taking care of them. Instead of freaking out go to a good ophthalmologist or go for a herbal remedy because that helps a lot without side effects.

Aug 28

What research is Benign Essential Tremor done?

While doing a research on Benign Essential Tremor we came across this aeticle on NINDS web portal. The title ‘What Research is Being Done?’ Caught our attention. Here we are pasting the same aticle or let’s say the para that was of interest to us.

What Research is Being Done?

The National Institute of Neurological Disorders and Stroke, a unit of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, is the nation’s leading federal funder of research on disorders of the brain and nervous system. The NINDS sponsors research on tremor both at its facilities at the NIH and through grants to medical centers.

Benign Essential Tremor

Scientists at the NINDS are evaluating the effectiveness of 1-octanol, a substance similar to alcohol but less intoxicating, for treating essential tremor. Results of two previous NIH studies have shown this agent to be promising as a potential new treatment.

Scientists are also studying the effectiveness of botulinum toxin as a treatment for a variety of involuntary movement disorders, including essential tremor of the hand.
We will be back with some new research soon because we love to share what we find.